Results 121 to 130 of about 8,387 (243)

EFFECT OF TRIMETAZIDINE ON MYOCARDIAL KARYOMETRY DURING THE DOXORUBICIN-CYCLOPHOSPHAMIDE MODE OF CHEMOTHERAPY PRESCRIPTION

open access: yesМедицина в Кузбассе, 2022
The subject of study. AC-mode of chemotherapy-induced cardiotoxicity, and rationality of trimetazidine prescription. Purpose of the study – research the nuclear apparatus state of rats cardiomyocytes on chronic in vivo model of cancer therapy-driven ...
Ашот Арманович Авагимян
doaj  

Flow Injection Analysis With Trimetazidine Dihydrochloride Ion-Selective Electrode

open access: yes, 2005
New Plastic membrane ion-selective electrode for trimetazidine dihydrochloride based on trimetazidinium-tetraphenylborate was prepared. The electrode exhibited mean calibration graph slope of 29.5 mV per decade of (TrimCl2) concentration at 25°C.
Nour Abdel-Ghani   +2 more
core   +1 more source

Trimetazidine Increases [\u3csup\u3e3\u3c/sup\u3eH]glucose Uptake in Rat Brain

open access: yes, 2006
Trimetazidine, a clinically effective antianginal agent with no negative inotropic or vascular properties, acts by optimizing cardiac energy metabolism through inhibition of free faty acid oxidation, shifting substrate utilization from fatty acids to ...
Gorzałek, Jarosław   +8 more
core   +1 more source

Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action

open access: yesКардиоваскулярная терапия и профилактика, 2008
Trimetazidine is proved to be a highly effective metabolic agent, compared to other drugs with the same action. Trimetazidine shifts cardiac energy metabolism from fatty acid oxidation towards glucose oxidation by inhibiting mitochondrial long-chain 3 ...
A. Yu. Gasparyan   +2 more
doaj  

ROLE OF TRIMETAZIDINE, A CYTOPROTECTIVE AGENT IN ISCHEMIC HEART DISEASE [PDF]

open access: yes, 2016
Objectives: Metabolic agents such as trimetazidine offer a benefits role of cytoprotection in ischemic heart disease (IHD) through an inhibition ofcardiac fatty acid oxidation and improving myocardial glucose utilization.
Manzoor, Sami   +4 more
core   +1 more source

Prevention of peritoneal adhesions in rats with trimetazidine

open access: yes, 1990
The effect of trimetazidine (an antianginal drug that acts as a scavenger of oxygen radicals) in the prevention of peritoneal adhesions induced by complete vascular obstruction of an ileal segment for 30 minutes followed by reperfusion was investigated ...
Page, P.   +5 more
core  

TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)

open access: yes, 2002
Trimetazidine and mildronate as direct action β2 - adrenosensibilizers (experimental evidence)
T. V. Bratchikova   +6 more
core  

Does trimetazidine prevent myocardial injury after percutaneous coronary intervention?

open access: yes, 2008
Trimetazidine has been known for years as being an effective, ‘‘patient-friendly’’, anti-anginal agent. Recent studies using the modified release formulation (Vastarel MR) have confirmed the efficacy of trimetazidine in stable ischemic heart disease ...
Mario Marzilli, MARZILLI, MARIO
core   +1 more source

Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease

open access: yesТерапевтический архив, 2004
Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova   +4 more
doaj  

Cliniko-experimental research of trimetazidine efficiency at the myocardium ischemia

open access: yesКардиоСоматика, 2013
The randomized controllable clinical research of Trimetazidine (Preductal MB) efficiency was spent at 95 patients with a stable angina pectoris. There were revealed the authentic increase in 2 times of treatment’s clinical efficiency in patients, who in ...
O. V Romashchenko
doaj  

Home - About - Disclaimer - Privacy